Clinical Trials Directory

Trials / Completed

CompletedNCT01868945

Dose Finding Study in Physically Frail Elderly to Measure 25(OH) Vitamin D Levels After Supplementation With Hy.D Calcifediol 25 SD/S and Vitamin D3

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
59 (actual)
Sponsor
dsm-firmenich Switzerland AG · Industry
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the dose of Hy.D Calcifediol 25 SD/S (a metabolite of vitamin D3) which will achieve the range of mean serum 25(OH)D between 75-100nmol/L in physically frail elderly people after 24 weeks of daily supplementation with different doses of Hy.D Calcifediol 25 SD/S compared to vitamin D3.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT5 µg/day Hy.D Calcifediol5 µg/day Hy.D Calcifediol taken together with breakfast for a total period of 24 weeks
DIETARY_SUPPLEMENT10 µg/day Hy.D Calcifediol10 µg/day Hy.D Calcifediol taken together with breakfast for a total period of 24 weeks
DIETARY_SUPPLEMENT15 µg/day Hy.D Calcifediol15 µg/day Hy.D Calcifediol taken together with breakfast for a total period of 24 weeks
DIETARY_SUPPLEMENT20 µg/day vitamin D320 µg/day vitamin D3 taken together with breakfast for a total period of 24 weeks

Timeline

Start date
2013-04-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2013-06-05
Last updated
2015-03-27

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01868945. Inclusion in this directory is not an endorsement.